How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q2 2020?

121 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q2 2020. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 52,961,450
Share change: -3,890,076
Total reported value: $1,111,646,885
Price per share: $20.99
Number of holders: 121
Value change: -$95,003,651
Number of buys: 74
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	18%	9,365,444	$216,436,000	—	31 Mar 2020	13F
BAUPOST GROUP LLC/MA	13F	Company	18%	9,309,168	$215,135,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	17%	8,780,790	$202,923,000	—	31 Mar 2020	13F
Link Fund Solutions Ltd	13F	Company	9.4%	4,836,864	$111,296,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	8.6%	4,433,056	$102,448,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	8.1%	4,167,523	$96,312,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	3.1%	1,576,715	$36,439,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	2.1%	1,057,513	$24,439,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	2.1%	1,055,268	$24,387,000	—	31 Mar 2020	13F
Chescapmanager LLC	13F	Company	1.9%	1,002,718	$23,173,000	—	31 Mar 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.9%	1,000,000	$23,110,000	—	31 Mar 2020	13F
Rubric Capital Management LP	13F	Company	1.7%	873,577	$20,188,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.5%	775,000	$17,910,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	1.5%	750,000	$17,333,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	719,072	$16,617,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	1.2%	622,170	$14,378,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	1.1%	547,669	$12,656,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1%	514,469	$11,889,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.93%	476,386	$11,010,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.81%	416,942	$9,636,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.78%	400,974	$9,267,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.54%	277,700	$7,028,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.59%	302,145	$6,982,000	—	31 Mar 2020	13F
Laurion Capital Management LP	13F	Company	0.58%	300,000	$6,933,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.58%	299,576	$6,924,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.44%	228,836	$5,288,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.41%	211,545	$4,889,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.41%	210,967	$4,875,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.39%	199,909	$4,620,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.33%	170,210	$3,934,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.27%	140,725	$3,252,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.2%	101,609	$2,348,000	—	31 Mar 2020	13F
Cormorant Asset Management, LP	13F	Company	0.19%	100,000	$2,311,000	—	31 Mar 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	0.18%	93,300	$2,156,000	—	31 Mar 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.17%	89,416	$2,066,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.16%	82,542	$1,908,000	—	31 Mar 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.16%	82,368	$1,903,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.15%	75,800	$1,752,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.14%	74,542	$1,723,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.13%	64,535	$1,491,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.12%	62,444	$1,443,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.11%	57,168	$1,321,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.11%	57,116	$1,320,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.08%	43,521	$1,005,000	—	31 Mar 2020	13F
CHICAGO EQUITY PARTNERS LLC	13F	Company	0.08%	43,480	$1,005,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.08%	42,200	$975,000	—	31 Mar 2020	13F
Engineers Gate Manager LP	13F	Company	0.08%	40,621	$939,000	—	31 Mar 2020	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.08%	40,000	$924,000	—	31 Mar 2020	13F
NJ State Employees Deferred Compensation Plan	13F	Company	0.07%	38,142	$881,000	—	31 Mar 2020	13F
361 CAPITAL LLC	13F	Company	0.07%	37,754	$872,000	—	31 Mar 2020	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q2 2020

As of 30 Jun 2020, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,961,450 shares. The largest 10 holders included FMR LLC, BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., ORBIMED ADVISORS LLC, AMERIPRISE FINANCIAL INC, NORGES BANK, JANE STREET GROUP, LLC, and STATE STREET CORP. This page lists 121 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

102

Q2 2020 holders

121

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.